Aug 6, 2026 07:30AM
May 7, 2026 07:30AM
May 7, 2026 07:30AM
Mar 12, 2026 12:26PM
Mar 11, 2026 08:00AM
Mar 5, 2026 06:59AM
Mar 3, 2026 05:31PM Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Jan 20, 2026 07:00AM
Jan 20, 2026 06:59AM
Jan 12, 2026 07:30AM
Nov 6, 2025 07:30AM
Oct 14, 2025 08:01AM Lexicon presents additional pilavapadin data for diabetic nerve pain
Oct 14, 2025 08:00AM
Sep 22, 2025 04:00PM
Sep 22, 2025 04:00PM
Sep 11, 2025 06:50AM
Sep 9, 2025 06:50AM
Sep 8, 2025 08:31AM
Sep 8, 2025 08:30AM Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
Sep 4, 2025 08:30AM
Sep 3, 2025 08:30AM
Sep 2, 2025 08:33AM
Sep 2, 2025 08:30AM
Aug 6, 2025 12:06PM
Aug 6, 2025 07:30AM
Jul 18, 2025 08:00AM Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025)
May 13, 2025 04:00PM
Mar 6, 2025 04:00PM
Mar 3, 2025 07:01AM
Mar 3, 2025 07:00AM
Dec 20, 2024 04:30PM
Nov 26, 2024 08:00AM
Nov 25, 2024 06:39AM Lexicon Pharmaceuticals (LXRX) PT Lowered to $4 at H.C. Wainwright
Nov 22, 2024 07:33AM
Nov 22, 2024 07:32AM
Nov 12, 2024 04:05PM
Nov 5, 2024 04:05PM
Nov 4, 2024 08:00AM
Nov 1, 2024 07:22AM
Nov 1, 2024 06:40AM Lexicon Pharmaceuticals (LXRX) PT Lowered to $6 at H.C. Wainwright
Oct 31, 2024 06:54PM
Oct 22, 2024 08:00AM
Oct 18, 2024 05:48AM
Oct 17, 2024 06:55AM
Oct 16, 2024 04:35PM
Oct 16, 2024 04:35PM
Oct 16, 2024 04:34PM Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
Sep 27, 2024 08:00AM

327,748 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All